Metabolic Companies

32 companies | Diabetes and metabolic disorders

#	COMPANY	TYPE	STAGE
1.	Acelot South San Francisco, California, USA	Biotech	Preclinical	VIEW
2.	Amgen Thousand Oaks, California, United States	Pharma	Discovery through Commercial	VIEW
3.	Anthem Biosciences Bangalore, India	CDMO	Commercial	VIEW
4.	Asklepios BioPharmaceutical Research Triangle Park, North Carolina, USA	Biotech	Phase 1\|Phase 2\|Preclinical	VIEW
5.	Blanchard Valley Health System Findlay, USA	MedTech	Commercial	VIEW
6.	Boehringer Ingelheim Ingelheim am Rhein, Germany (near Mainz and Frankfurt)	Pharma	Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
7.	CEMKA Bourg-la-Reine, France	CRO	Commercial	VIEW
8.	Capgemini Paris, France	Digital Health	Commercial	VIEW
9.	Celltrion Incheon, South Korea	Pharma	Commercial	VIEW
10.	Centogene Rostock, Germany	Diagnostics	Preclinical	VIEW
11.	Cliantha Research Ahmedabad, India	CRO	Commercial	VIEW
12.	ColigoMed Sunnyvale, USA	Digital Health	Commercial	VIEW
13.	Corline Biomedical AB Uppsala, Sweden	Biotech	Phase 2	VIEW
14.	Curadev Pharma Pvt Ltd Noida, India	Biotech	Phase 1	VIEW
15.	Cuttsy+Cuttsy Cambridge, United Kingdom	CRO	N/A (Service Provider)	VIEW
16.	Cytorex Biosciences Weston, Florida, USA	Biotech	Preclinical	VIEW
17.	IQVIA Durham, North Carolina, United States (Primary) / Danbury, Connecticut, United States (Secondary)	CRO	N/A - Service Provider	VIEW
18.	Keenova Therapeutics (formerly Endo Pharmaceuticals/Mallinckrodt Specialty Brands) Dublin, Ireland	Pharma	Commercial\|Phase 1-3	VIEW
19.	Life Science Strategy Group Menlo Park, USA	CRO	Commercial	VIEW
20.	MSD Rahway, New Jersey, USA	Pharma	Commercial	VIEW
21.	Nova Biomedical Waltham, USA	MedTech	Commercial	VIEW
22.	Novo Nordisk Bagsværd, Denmark	Pharma	Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
23.	Pfizer New York, United States	Pharma	Phase 1-3 and pending approval	VIEW
24.	Ridgeline Discovery Basel, Switzerland	Biotech	Discovery\|Preclinical\|Phase 1\|Phase 2	VIEW
25.	SNIPR Biome Copenhagen, Denmark	Biotech	Phase 1b-2a	VIEW
26.	Sanofi Paris, France	Pharma	Preclinical through Phase 3	VIEW
27.	Scenic Biotech Amsterdam, The Netherlands	Biotech	Preclinical to IND-enabling	VIEW
28.	Soleno Therapeutics, Inc. Redwood City, California, USA	Biotech	Commercial	VIEW
29.	UK Biobank Stockport, United Kingdom	Diagnostics	Commercial	VIEW
30.	University of Wisconsin–Madison Madison, USA	Biotech	Commercial	VIEW
31.	Vasa Therapeutics Encinitas, USA	Biotech	Phase 1	VIEW
32.	Zydus Lifesciences Limited Ahmedabad, India	Pharma	Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW